Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11998620 PSMA targeted compounds and uses thereof

Patent 11998620 was granted and assigned to Case Western Reserve University on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Case Western Reserve University

0

Current Assignee

Case Western Reserve University

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Xinning Wang0

Zhenghong Lee0

James Basilion0

Date of Patent

June 4, 2024

0

Patent Application Number

184569310

Date Filed

August 28, 2023

0

Patent Citations

US Patent 8609721 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase

0

US Patent 8778305 PSMA-binding agents and uses thereof

0

US Patent 8907058 PSMA binding ligand-linker conjugates and methods for using

0

US Patent 9056841 PSMA-targeting compounds and uses thereof

0

US Patent 9192302 Intra-operative molecular imaging

0

US Patent 9193763 PSMA binding ligand-linker conjugates and methods for using

0

US Patent 9226981 PSMA-binding agents and uses thereof

0

US Patent 9271653 Intra-operative molecular imaging

0

...

Patent Primary Examiner

Michael G. Hartley

0

CPC Code

0

0

0

Patent abstract

PSMA targeted compounds, pharmaceutical compositions comprising these compounds, and methods for treating and detecting cancers in a subject are described herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11998620 PSMA targeted compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.